Dental scanning solutions firm Medit names Han Ryu as new CEO

최혜진 2024. 6. 27. 15:04
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Medit, a dental 3-D-scanning solutions provider backed by private equity fund MBK Partners, said Thursday that it appointed Han Ryu as its new CEO.
Medit CEO Han Ryu [MEDIT]

Medit, a dental 3-D-scanning solutions provider backed by private equity fund MBK Partners, said Thursday that it appointed Han Ryu as its new CEO.

With the appointment of the new head, Medit plans to strengthen its innovation pipeline and accelerate growth in its global business.

Ryu has over 30 years of senior management experience in multiple U.S. medical and healthcare companies such as Qorvo Biotechnologies and Siemens Healthineers.

Since 2023, he has led Medit North America, driving growth in the regional market. As Medit’s chief growth & strategy officer, he restructured global sales and marketing and oversaw new product launches.

With Ryu's global management leadership and strategic expertise in driving innovation and growth, Medit is expected to focus more on customer-centered innovation, enhance strategic partnerships, and strengthen new product development.

"I am truly honored to lead Medit as CEO. Medit's open innovation model and unwavering passion for care improvement perfectly align with my vision. We will accelerate the digital dental revolution with a customer-centric approach," the company's CEO Ryu said.

Medit recently launched an intraoral scanner, the Medit i900, which is designed to enhance dental scanning processes.

The company specializes in developing state-of-the-art 3-D intraoral scanners and comprehensive dental solutions. It develops and produces dental and industrial 3-D scanners and related software based on 3-D measurement technology, developed entirely with Korean technology.

BY CHOI HAE-JIN [choi.haejin@joongang.co.kr]

Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.

이 기사에 대해 어떻게 생각하시나요?